GlassScriptPhysician profile
Carla Deanne Gilbert
NPI 1669021523
$4,905.25
in general payments reported to CMS, 2019-2025
37 companies · $862 in 2025
The $862 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $637 · 2022: $724 · 2023: $1,945 · 2024: $737 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,703 · Travel and Lodging: $814 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.06 |
| Travel and Lodging | $814.20 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,106.91 | 2022-2024 | Axonics |
| Abbvie INC. | $480.15 | 2021-2025 | |
| Astellas Pharma US INC | $357.61 | 2021-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $308.44 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $296.59 | 2022 | |
| Sumitomo Pharma America, INC. | $272.74 | 2023-2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $233.89 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $223.82 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $179.90 | 2021-2025 | Spravato |
| Medtronic, INC. | $152.63 | 2023 | Interstim, Intellis Adaptivestim |
| Lilly USA, LLC | $139.59 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Biohaven Pharmaceuticals, INC. | $111.18 | 2021 | |
| Teleflex LLC | $108.82 | 2021 | |
| Antares Pharma, INC. | $101.84 | 2024-2025 | Xyosted |
| Si-Bone, INC. | $99.34 | 2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.04 | 2022-2024 | Xifaxan |
| Convatec INC. | $91.90 | 2023-2025 | |
| Halozyme INC | $91.54 | 2023 | |
| Boston Scientific Corporation | $68.29 | 2024-2025 | Bodyguardian, Cds - Mct/Cem Monitoring, Axonics |
| Procept Biorobotics Corporation | $46.64 | 2024 | Aquabeam System |
| Verona Pharma, INC. | $38.46 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $33.10 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $29.18 | 2025 | Farxiga |
| Madrigal Pharmaceuticals | $28.80 | 2025 | Rezdiffra |
| Mylan Specialty L.P. | $25.57 | 2022 | |
| Valinor Pharma, LLC | $19.83 | 2025 | Movantik |
| Pfizer INC. | $19.79 | 2025 | |
| Ardelyx, INC. | $18.10 | 2025 | Ibsrela |
| Dexcom, INC. | $17.57 | 2022 | |
| Radius Health, INC. | $16.13 | 2021 | |
| Smith+Nephew, INC. | $15.16 | 2025 | Iodosorb Ointment 40g USA, Regranex, Collagenase Santyl |
| Teva Pharmaceuticals USA, INC. | $13.82 | 2022 | |
| Endo Pharmaceuticals INC. | $13.69 | 2021 | |
| Avanos Medical | $12.88 | 2023 | On-Q* Pump and Accessories |
| Idorsia Pharmaceuticals US INC | $12.71 | 2023 | Quviviq |
| Glaxosmithkline, LLC. | $12.46 | 2022 | |
| Genentech USA, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.